<p>In patients with major depression disorder it is, thanks to use of artificial intelligence, now possible to predict within a week whether an antidepressant will work. With the help of an AI algorithm, a brain scan and an individual's clinical information, researchers from Amsterdam UMC and Radboudumc could see up to 8 weeks faster whether or not the medication would work. The results of this study are published today in the American Journal of Psychiatry.</p>
Alirocumab every 2 or 4 weeks significantly reduced LDL-C in pediatric patients with inadequately controlled heterozygous familial hypercholesterolemia.
Alzheimer's disease (AD) is linked to harmful protein accumulations in the brain, primarily β-amyloid (Aβ) aggregates known as plaques, which are central to the disease's pathology. Entresto (sacubitril/valsartan) is a combined neprilysin inhibitor and angiotensin receptor blocker, approved for the